CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Henan Taloph Pharmaceutical Stock Company Limited Company Snapshot
Henan Taloph Pharmaceutical Stock Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Henan Taloph Pharmaceutical Stock Company Limited with three other companies in this sector in China: Anhui Anke Biotechnology (Group) Company., Limited (2017 sales of 1.10 billion Chinese Renmimbi [US$157.60 million] of which 58% was Biological Products), Sinovac Biotech Ltd (1.17 billion Chinese Renmimbi [US$168.80 million] of which 70% was Enterovirus 71 vaccines), and Hybio Pharmaceutical Co Ltd (1.25 billion Chinese Renmimbi [US$179.16 million] of which 100% was Medical and Pharmaceutical Manufacturing).

Sales Analysis. Henan Taloph Pharmaceutical Stock Company Limited reported sales of 1.17 billion Chinese Renmimbi (US$167.97 million) for the year ending December of 2017. This represents an increase of 22.6% versus 2016, when the company's sales were 953.31 million Chinese Renmimbi. The sales level in 2017 was fairly close to the level five years ago: in 2012, Henan Taloph Pharmaceutical Stock Company Limited had sales of 1.09 billion Chinese Renmimbi. Sales of Medicine Distribute saw an increase that was more than double the company's growth rate: sales were up 60.1% in 2017, from 194.55 million Chinese Renmimbi to 311.48 million Chinese Renmimbi. Henan Taloph Pharmaceutical Stock Company Limited also saw significant increases in sales in Medicine R&d (up 33.7% to 123.90 million Chinese Renmimbi) . Not all segments of Henan Taloph Pharmaceutical Stock Company Limited experienced an increase in sales in 2017: sales of Other Industry fell 31.5% to 2.21 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Henan Taloph Pharmaceutical Stock Company Limited
  Stock Performance Chart for Henan Taloph Pharmaceutical Stock Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 3.72
(Figures in Chinese Renmimbi)
1 Week 3.9%   13 Weeks 11.4%  
4 Weeks -13.3%   52 Weeks -38.6%  
 
Henan Taloph Pharmaceutical Stock Company Limited Key Data:
  Ticker: 600222 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 1,168,389,660
(Year Ending Jan 2018).
Employees: 1,675
  Currency: Chinese Renmimbi Market Cap: 2,134,856,973
  Fiscal Yr Ends: December Shares Outstanding: 573,886,283
  Share Type: A Gu Closely Held Shares: 217,060,738
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.